boston.com Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Comments
Send your comments and tips to whitecoat@globe.com
Categories


Blogger
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Contributors
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« UMass Amherst brings back public health bachelor's | Main | On the blogs: healthcare law link, falls on the way home »

Friday, April 13, 2007

Today's Globe: "stuck kids," drug-resistant gonorrhea, disabled veterans, monkey gene map, obesity-risk gene, Arcoxia

The state's mental health system for children is clogged with some of its worst backups in years, leading to long emergency room waits and a record number of "stuck kids" who are deemed well enough to leave hospital units but have nowhere to go.

Antibiotic-resistant gonorrhea is spreading rapidly across the United States, federal health officials reported yesterday, raising alarm about doctors' ability to treat the common sexually transmitted infection.

The Army might be shortchanging injured soldiers by rating the severity of their disabilities with a system that is both unwieldy and inconsistent, the head of a special commission said yesterday.

Scientists have unraveled the DNA of another of our primate relatives, this time a monkey named the rhesus macaque -- and the work has far more immediate impact than just to study evolution.

British researchers have produced the first clear evidence for a gene common in the population that dictates why some people gain excess weight while others do not.

Merck & Co.'s experimental arthritis drug Arcoxia shouldn't be allowed on the US market, a Food and Drug Administration advisory panel said, citing some of the same risks that led to the withdrawal of the similar treatment Vioxx.

Posted by Elizabeth Cooney at 06:17 AM
Sponsored Links